Comparative study of in vitro activity of tedizolid and linezolid against Mycobacterium avium complex.
Open Access
- 18 July 2022
- journal article
- research article
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 30, 395-398
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung DiseaseAntimicrobial Agents and Chemotherapy, 2016
- Linezolid versus vancomycin for skin and soft tissue infectionsCochrane Database of Systematic Reviews, 2016
- Epidemiology of Human Pulmonary Infection with Nontuberculous MycobacteriaClinics in Chest Medicine, 2015
- Tedizolid: A new oxazolidinone antimicrobialAmerican Journal of Health-System Pharmacy, 2014
- Resistance to Linezolid Caused by Modifications at Its Binding Site on the RibosomeAntimicrobial Agents and Chemotherapy, 2012
- In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococciJournal of Antimicrobial Chemotherapy, 2011
- Structure-Activity Relationships of Diverse Oxazolidinones for Linezolid-Resistant Staphylococcus aureus Strains Possessing the cfr Methyltransferase Gene or Ribosomal MutationsAntimicrobial Agents and Chemotherapy, 2010
- In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant StrainsAntimicrobial Agents and Chemotherapy, 2008
- Multicenter Laboratory Validation of the BACTEC MGIT 960 Technique for Testing Susceptibilities of Mycobacterium tuberculosis to Classical Second-Line Drugs and Newer AntimicrobialsJournal of Clinical Microbiology, 2006
- Antimicrobial Resistance to LinezolidClinical Infectious Diseases, 2004